Bilcare
64.14
+1.00(+1.58%)
Market Cap₹151.02 Cr
PE Ratio-8.61
IndustryHealthcare
Company Performance:
1D+1.58%
1M+2.95%
6M+0.69%
1Y+0.69%
5Y+0.69%
View Company Insightsright
More news about Bilcare
13Feb 26
Bilcare Limited Reports Mixed Q3FY26 Results with Strong Standalone Performance Offset by Consolidated Losses
Bilcare Limited announced Q3FY26 financial results showing contrasting performance between standalone and consolidated operations. While standalone net profit grew 50.56% to ₹2.71 crores, consolidated operations reported ₹12.81 crores loss despite improvement from previous year. The company also disclosed major corporate actions involving subsidiary Caprihans India Limited including preference share redemption and convertible warrant conversion.
 no imag found
18Aug 25
Bilcare Limited Reports Narrowed Losses in Q1 Amid Challenging Market Conditions
Bilcare Limited's Q1 FY2024 results show a mixed performance. Consolidated total income decreased by 2.75% to ₹192.44 crores, but net loss reduced to ₹9.76 crores from ₹15.02 crores year-over-year. Standalone performance improved with profit after tax more than doubling to ₹3.59 crores. Consolidated EPS improved to ₹(1.59) from ₹(2.71) in the previous year.
 no imag found
21Jul 25
Bilcare Approves Voluntary Liquidation of UK Subsidiary Bilcare GCS
Bilcare Limited's Board of Directors has approved the voluntary liquidation of its wholly-owned UK subsidiary, Bilcare GCS Limited. The decision was made on July 21, 2025. Bilcare GCS contributed only 0.02% to the consolidated turnover with INR 11.88 lacs in FY 2024-25. The liquidation is not expected to significantly impact Bilcare Limited's overall financial position. The process will be carried out in accordance with UK laws, with the completion date yet to be determined.
 no imag found
Bilcare
64.14
+1.00
(+1.58%)
1 Year Returns:+0.69%
Industry Peers
Syngene International
434.25
(-0.30%)
Indegene
523.00
(+0.96%)
Suven Life Sciences
237.35
(-10.89%)
Vimta Labs
544.35
(+6.06%)
Take Solutions
29.57
(-0.34%)
Bilcare
64.14
(+1.58%)
Adeshwar Meditex
18.41
(0.0%)
Vanta Bioscience
22.02
(-4.96%)